Based on our limited examination, we found that EFHD2 was expressed in numerous types of tumor cells with highly metastatic potential, including breast cancer, pancreatic cancer, and gastric cancer, but it is undetectable in liver tumor cells. The gene discussed is EFHD2; the disease is breast cancer.